Pacira BioSciences
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
公司地址 2000 Sierra Point Parkway, Suite 900, Brisbane, CA, USA, 94005
電話號碼 +1 650 242-8052
傳真號碼 --
公司網頁 https://www.pacira.com
員工數量 829
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Lauren Riker Principal Accounting Officer and Senior Vice President, Finance -- 26/02/2026
Ms. Kristen Marie Williams Chief Administrative Officer and Secretary 美元 545.08K 28/04/2026
Mr. Shawn M. Cross Chief Financial Officer 美元 525.00K 28/04/2026
Mr. Frank D. Lee Director and Chief Executive Officer 美元 935.31K 28/04/2026
Dr. Jonathan Slonin, M.D. Chief Medical Officer 美元 555.99K 28/04/2026
Mr. Brendan P. Teehan Chief Commercial Officer 美元 497.39K 28/04/2026
 
董事會成員
董事會 職務 更新日期
Ms. Laura A. Brege Chairman of the Board 28/04/2026
Mr. Thomas G. Wiggans Independent Director 28/04/2026
Mr. Michael J. Yang Independent Director 28/04/2026
Dr. Mark I. Froimson, M.D. Independent Director 28/04/2026
Dr. Samit Hirawat, M.D. Independent Director 28/01/2026
Governor Christopher J. Christie Independent Director 28/04/2026
Mr. Frank D. Lee Director and Chief Executive Officer 28/04/2026
Ms. Alethia Young Independent Director 28/04/2026
Dr. Marcelo Bigal, M.D.,PhD Independent Director 28/04/2026
 
所屬ETF (更新日期: 01/08/2026 04:21)
代號 名稱 佔比% ▼ 持有日期
PLTLPrincipal US Small-Cap Adptv Mlt-Fac ETF0.0001%30/09/2023
HDGProShares Hedge Replication0.0001%28/07/2026
RBProshares Russell 2000 Dynamic BufferETF0.00003%28/07/2026
ACSVAmerican Century Small Cp Val Insgts ETF<0.000001%03/06/2026
AIEQAI Powered Equity ETF<0.000001%03/05/2023
AOMiShares Core 40/60 Moderate Allc ETF<0.000001%06/03/2026
EHLSEven Herd Long Short ETF<0.000001%13/11/2025
EWSCInvesco S&P SmallCap 600® Equal Wt ETF<0.000001%20/03/2023
FADFirst Trust Multi Cap Gr AlphaDEX® ETF<0.000001%08/04/2026
FEACFidelity Enhanced U.S. All-Cap Eq ETF<0.000001%04/03/2026
FYCFirst Trust Small Cap Gr AlphaDEX® ETF<0.000001%08/04/2026
FYXFirst Trust Small Cap Core AlphaDEX® ETF<0.000001%08/04/2026
HKNDHumankind US Stock ETF<0.000001%24/11/2025
IJSiShares S&P Small-Cap 600 Value ETF<0.000001%06/03/2026
ISCGiShares Morningstar Small-Cap Growth ETF<0.000001%06/03/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF<0.000001%02/07/2026
OASCOneAscent Enhanced Small and Mid Cap ETF<0.000001%13/11/2025
ONEQFidelity Nasdaq Composite ETF<0.000001%19/12/2025
PJPInvesco Pharmaceuticals ETF<0.000001%03/12/2025
PRAYFIS Christian Stock ETF<0.000001%05/03/2026
  1    2    3    4    5   6    7  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.